- Home
- SNTI vs LUD Comparison
SNTI vs LUD Comparison
Compare SNTI & LUD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNTI
- LUD
- Stock Information
- Founded
- SNTI 2016
- LUD 2004
- Country
- SNTI United States
- LUD Hong Kong
- Employees
- SNTI N/A
- LUD N/A
- Industry
- SNTI Biotechnology: Pharmaceutical Preparations
- LUD
- Sector
- SNTI Health Care
- LUD
- Exchange
- SNTI Nasdaq
- LUD NYSE
- Market Cap
- SNTI 85.3M
- LUD 96.7M
- IPO Year
- SNTI N/A
- LUD 2025
- Fundamental
- Price
- SNTI $2.26
- LUD N/A
- Analyst Decision
- SNTI Strong Buy
- LUD
- Analyst Count
- SNTI 2
- LUD 0
- Target Price
- SNTI $8.50
- LUD N/A
- AVG Volume (30 Days)
- SNTI 385.8K
- LUD 34.9K
- Earning Date
- SNTI 08-12-2025
- LUD 01-01-0001
- Dividend Yield
- SNTI N/A
- LUD N/A
- EPS Growth
- SNTI N/A
- LUD N/A
- EPS
- SNTI N/A
- LUD N/A
- Revenue
- SNTI N/A
- LUD $44,863,430.00
- Revenue This Year
- SNTI N/A
- LUD N/A
- Revenue Next Year
- SNTI $150.00
- LUD N/A
- P/E Ratio
- SNTI N/A
- LUD N/A
- Revenue Growth
- SNTI N/A
- LUD N/A
- 52 Week Low
- SNTI $1.52
- LUD $3.40
- 52 Week High
- SNTI $16.94
- LUD $8.00
- Technical
- Relative Strength Index (RSI)
- SNTI 37.88
- LUD N/A
- Support Level
- SNTI $2.05
- LUD N/A
- Resistance Level
- SNTI $2.35
- LUD N/A
- Average True Range (ATR)
- SNTI 0.30
- LUD 0.00
- MACD
- SNTI 0.00
- LUD 0.00
- Stochastic Oscillator
- SNTI 20.00
- LUD 0.00
About SNTI Senti Biosciences Inc.
Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.
About LUD LUDA TECHNOLOGY GROUP LIMITED
Luda Technology Group Ltd is a company that is principally engaged in the manufacture and sale of stainless steel and carbon steel flanges and fittings products and trading of steel pipes, valves, and other steel tubing products.